Role of biological sex in normal cardiac function and in its disease outcome - A review

Journal of Clinical and Diagnostic Research

Volumn 8, Issue 8, 2014, Pages

  Prabhavathi, K ^a   Tamarai Selvi, K ^a   Poornima, K N ^a   Sarvanan, A ^a  

^a SRM INSTITUTE OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

Estrogen; Gender; Testosterone

Indexed keywords

ADRENERGIC RECEPTOR; ESTROGEN; GLYCOGEN SYNTHASE KINASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; RELAXIN; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA;

AORTA CONSTRICTION; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; EXERCISE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HEART OUTPUT; HEART PROTECTION; HEART RATE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; NONHUMAN; PREMENOPAUSE; PROTEIN EXPRESSION; SEX DIFFERENCE; SPONTANEOUSLY HYPERTENSIVE HEART FAILURE RAT; SURVIVAL RATE;

EID: 84907312970     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2014/9635.4771     Document Type: Article

References (47)

1. De Simone G, Devereux RB, Daniels SR, Meyer RA. Gender differences in left ventricular growth. Hypertension.1995;26:979-83.
2. Zak R. Development and proliferative capacity of cardiac muscle cells. Circ Res.1974;35(II): 17-26.
3. European Heart Journal; Heart Rate Variability and Heart Rate in Healthy Volunteers; D. Ramakers, et al. 1998.
4. Grandi AM, Venco A, Barzizza F, Scalise F, Pantaleo P, Finardi G. Influence of age and sex on left ventricular anatomy and function in normals. Cardiology.1992;81:8-13.
5. Olivertti G, Giordano G, Corradi D, Melissari M, Lagrasta C, et al. Gender differences and ageing: effects on human heart. J Am Cool Cardiol. 1995;26:1068-79.
6. Sullivan MJ, Cobb FR, Higginbotham MB. Stroke volume increases by similar mechanisms during upright exercise in normal men and women. Am J Cardiol. 1991;67:1405-12.
7. Higginbotham MB, Morris KG, Coleman RE, Cobb Fr,. Sex related differences in the normal cardiac response to upright exercise. Circulation. 1984;70:357-66.
8. Deswal A, Bozkurt B. Comparison of morbidity in a women versus men with heart failure and preserved ejection fraction. Am J Cardiol.2006;97:1228-31.
9. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex based differences in early mortality after myocardial infarction. National Registry of Myocardial infarction 2 Participants. N England J med.1999;341:217-25.
10. Hofman A, Grobbe DE, de Jong PT, Van Den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdan elderly study. Eur JEpidemiol.1991;7:403-22.
11. Douglas PS, Kartz SE, Weinberg EO, Chen MH, Bishop SP, Lorell BH. Hypertrophic remodelling: gender differences in the early response of left ventricular pressure overload. J Am Coll cardiol.1998;32:1118-25.
12. Ni H. Prevalence of self reported heart failure among US adults: results from the 1999 National Health Interview survey. Am heart J.2003;146:121-28.
13. Lindfeld J, Krause-Steinrauf H, Salerno J. Where are all the women with heart failure? J Am Coll cardiol.1997;30:1417-19.
14. Mohan SB, Parker M, Wehbi M, Douglass P. Idiopathic dilated cardiomyopathy: a common but mystifying cause of heart failure. Cleve. Clin J Med.2002;69:481-7
15. Fernandez-Sola J, Nicolas-Arfelis JM. Gender differences in alcoholic cardiomyopathy. J Gend Specif Med.2002;5:41-47.
16. Mole PA.increased contractile potential of papillary muscles from exercise trained rat hearts. Am J Phsiol.1978;234:H421-25.
17. Cavasin MA, Tao Z, Menon S, Yang XP. Gender differences in cardiac function during early remodelling after acute myocardial infarction in mice. Life Sci. 2004;75:2181-92.
18. Gerdes AM, Onodera T, Wang X, McCune SA. Myocyte remodelling during the progression to failure in rats with hypertension. Hypeetension.1996;28:609-14.
19. Stauffer BL, Konhilas JP, Luczak ED, Leinwand LA. Soy diet worsens heart disease in mice. J Clin Investig.2006;116:209-16.
20. Geister-Lowrance AA, Kass S, Tanigawa G, Vosberg HP, Mc Kenna W, et al. A molecular basis for familial hypertrophic cardiomyopathy: a β cardiac myosin heavy chain gene missense mutation. Cell.1990;62:999-1006.
21. Maass AH, Ikeda K, Oberdorf-Maass S, Maier SK, Leinwand LA. Hypertrophy, fibrosis and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T. Circulation. 2004;110:2102-09.
22. Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, et al.Tumor necrosis factor soluble receptor in patients with various degrees of congestive heart failure. Circulation.1995;92:1479-86.
23. Kubota T, McTiernan CF, Frye CS, et al. Dilated cardiomyopathy in transgenic mice with cardiac specific overexpression of tumor necrosis factor α. Circ res.1997;81:627-35.
24. Gao XM, agrotis A, Autelitano DJ, Percy E, Woodcock EA, et al. sex hormone and cardiomyopathic phenotype induced by cardiac β2-adrenergic receptor overexpression. Endocrinology. 2003;144;4097-105.
25. O'Connell t D, Ishizaka S, Nakamura A, Swigart PM, Rodrigo MC, et al. The α1 A/C and α 1B adrenergic receptors are required for physiological cardiac hypertrophy in the double knock out mouse. J Clin investig.2003;111:1783-91.
26. Djouadi F, Weinheimer CJ, Saffitz JE, Pitchford C, Bastin J, et al. A gender related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor α-deficient mice. J clin investig.1998;102:1083-91.
27. Nohammer C, Brunner F, Wolkart G, Staber PB, Steyrer E, et al.Myocardial dysfunction and male mortality in peroxisome proliferator activated receptor α knockout mice overexpressing lipoprotein lipase in muscle. Lab investig.2003;83:259-69.
28. Osheroff PL, Ho WH.Expression of relaxin mRNA and relaxin receptors in postnatal and adult rat brains and hearts. Localization and developmental patterns. J Biol Chem. 1993;268(20):15193-99.
29. Du XJ, Samuel CS, Gao XM, Zhao L, Parry LJ, Treagear GW. Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype. Cardiovasc Res.2003;57:395-404.
30. Antos CL, Mc Kinsey TA, Frey N, Kutschke W, McAnally J, et al. Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo. Proc Natl Acad Sci USA.2002; 00-907-12.
31. Luckey SW, Mansoori J, Fari K, Antos CL, Olson EN, Leinwand LA. Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males. Am J Physiol Heart Circ Physiol.2007;292;H838-45.
32. Gabel SA, Walker VR, London RE, Steenbergn C, Korach KS, Murphy E. Estrogen receptor β mediates gender differences in ischaemia/reperfusion injury. J Mol Cell Cardiol.2005;38:289-97.
33. Skavdhal M, Steenbergn C, Clark J, Myers P, Demianenko T, et al. estrogen receptor-β mediates male-female differences in the development of pressure overload hypertrophy. Am J Physiol heart circ physiol.2005;288:H469-76.
34. Brower GL, Gardner JD, Janicki JS. Gender mediated cardiac protection from adverse ventricular remodelling is abolished by ovariectomy. Mol Cell Biochem.2003;251:89-95.
35. Bhuiyan MS, Shioda N, Fukunga K. Ovariectomy augments pressure overload induced hypertrophy associated with changes in Akt and nitric oxide synthase signalling pathways in female rats. Am J Physiol Endocrinol Meatab.2007;293:E1606-14.
36. Vickers MR, Macleannan AH, Lawton B, Ford d, Martin J, et al.Main morbidities recorded in women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women. Br med J.2007;335:239.
37. Chu SH, Goldspink P, Kowalski J, Beck J, Schwertz DW.Effect of estrogen on calcium-handling proteins, β-adrenergic receptors, and function in rat heart. Life Sci.2006;79:1257-67.
38. Johnson BD, Zheng W, Korach KS, Scheuer T, Catterall WA, Rubanyi GM. Increased expression of the cardiac L-type calcium channel in estrogen receptor-deficient mice.J Gen Physiol.1997;110:135;40.
39. Jiang C, Poole-Wilson PA, Sarrel PM, Mochizuki S, Collins P, MacLeod KT. Effect of 17β-esradiol on contraction, Ca2+ current and intracellular free Ca2+ in guinea-pig isolated cardiac myocytes. Br J Pahrmacol.1992;106:739-45.
40. Kravstov GM, Kam KW, Liu J, Wu S, Wong TM. Altered Ca2+ handling by raynodine receptor and Na+-Ca+ exchange in the heart from ovariectomized rats: role of protein kinase. A Am J Physiol Cell Physiol.2007;292:C1625-35.
41. Patten RD, Pourati I, Aronovitz MJ, Baur J, Celestin F, et al. 17β-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phosphor-inositide-3kinase/Akt signalling.Circ Res.2004;95:692-99.
42. Shiraishi I, Melendez J, Ahn Y, Skavdahl M, Murphy E, et al.Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes.Circ Res.2004;94:884-91.
43. Camper-Kirby d, Welch S, walker A, Shiraishi I, Setchell KDR, et al. Myocardial Akt activation and gender:increased nuclear activity in females versus males. Circ Res.2001;88:1020-27.
44. Cavasin MA, Sankey SS, Yu AL, Menon S, Yang XP. Estrogen and testosterone have opposing effects on chronic cardiac remodelling and function in mice with myocardial infarction. Am J Physiol Heart Circ Physiol.2003;284:H1560-69.
45. Sluijmer AV, Heineman MJ, De Jong FH, Evers JL. Endocrine activity of the postmenopausal ovary: the effects of pituitary down regulation and oophorectomy. J Clin Endocrinol Metab. 1995;80:2163-67.
46. Sactleben TR, Berg KE, Elias BA, Cheatham JP, Felix GL, Hofschire PJ. The effects of anabolic steroids on myocardial structure and cardiovascular fitness. M Sci Sports Exerc.1993;25:1240-45.
47. Sullivan ML, Martinez CM, Gennis P, Gallagher EJ. The cardiac toxicity of anabolic steroids.Prog Cardiovac Dis. 1998;41:1-15.